POST Online Media Lite Edition


Aptuit names Jonathan Goldman as CEO

Staff writer |
Greenwich, Ct., USA - December 2, 2013, Greenwich, Ct., USA - Aptuit LLC, a pharmaceutical services company, announced the appointment of Jonathan Goldman as chief executive officer.

Article continues below

Dr. Goldman joins the company after achieving significant success at ICON Clinical Research, a global Contract Research Organization that specializes in the provision of clinical and other solutions that support Phase I-IV clinical studies. At ICON, Dr. Goldman was most recently Executive Vice President, Global Strategic and Business Development and a member of the senior leadership team.

Previously, his roles at ICON included Executive Vice President, Operations, Strategic Programs and Chief Medical Officer, ICON Medical Imaging.

Before joining ICON, Dr. Goldman served for 7 years as the Chief Medical Officer of POINT Biomedical, a US-based biopharmaceutical company that discovered and developed microsphere technologies and drugs.

In addition, he has held honorary academic positions of increasing responsibility at the University of California since 2000, most recently as Associate Clinical Professor of Medicine in the Division of Cardiology.

LATEST 5 MOVES FROM Connecticut 

What to read next

Jonathan Symonds joins HSBC Holdings board
Catalent Pharma Solutions appoints new leader
HSBC appoints Sir Jonathan Evans as director